IL259093A - Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity - Google Patents
Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneityInfo
- Publication number
- IL259093A IL259093A IL259093A IL25909318A IL259093A IL 259093 A IL259093 A IL 259093A IL 259093 A IL259093 A IL 259093A IL 25909318 A IL25909318 A IL 25909318A IL 259093 A IL259093 A IL 259093A
- Authority
- IL
- Israel
- Prior art keywords
- disease
- ctcs
- blood
- cancer cells
- heterogeneity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250422P | 2015-11-03 | 2015-11-03 | |
| PCT/US2016/059877 WO2017079139A1 (en) | 2015-11-03 | 2016-11-01 | Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL259093A true IL259093A (en) | 2018-06-28 |
Family
ID=58662599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL259093A IL259093A (en) | 2015-11-03 | 2018-05-02 | Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20180321247A1 (https=) |
| EP (1) | EP3371327B1 (https=) |
| JP (1) | JP7043412B2 (https=) |
| CN (2) | CN115341033A (https=) |
| AU (2) | AU2016348401A1 (https=) |
| CA (1) | CA3004150A1 (https=) |
| EA (1) | EA201891085A1 (https=) |
| IL (1) | IL259093A (https=) |
| WO (1) | WO2017079139A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011050103A1 (en) | 2009-10-21 | 2011-04-28 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| EP3108246B1 (en) | 2014-02-21 | 2019-10-09 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
| AU2020245775B2 (en) * | 2019-03-28 | 2025-07-10 | Lundoch Diagnostics AB | Use of follistatin in type 2 diabetes risk prediction |
| US12412272B2 (en) | 2019-11-26 | 2025-09-09 | University Of Cincinnati | Characterizing intra-site tumor heterogeneity |
| CN117497044A (zh) * | 2022-03-09 | 2024-02-02 | 复旦大学 | 基于单细胞基因组拷贝数变异谱在制造细胞良恶性诊断试剂或检测试剂中的应用 |
| WO2024192141A1 (en) | 2023-03-13 | 2024-09-19 | Dana-Farber Cancer Institute, Inc. | Treatment of cancers having a drug-resistant mesenchymal cell state |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014047285A1 (en) * | 2012-09-19 | 2014-03-27 | Paraskevi Giannakakou | Identifying taxane sensitivity in prostate cancer patients |
| AU2014248007B2 (en) | 2013-04-05 | 2020-03-26 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
| WO2015048740A1 (en) * | 2013-09-30 | 2015-04-02 | The Scripps Research Institute | Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients |
| US20150147339A1 (en) * | 2013-11-15 | 2015-05-28 | Psma Development Company, Llc | Biomarkers for psma targeted therapy for prostate cancer |
| CA2937051A1 (en) * | 2014-01-17 | 2015-07-23 | Ontario Institute For Cancer Research (Oicr) | Biopsy-driven genomic signature for prostate cancer prognosis |
| US10527624B2 (en) * | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| US20150212089A1 (en) * | 2014-01-30 | 2015-07-30 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies |
-
2016
- 2016-11-01 EP EP16862785.9A patent/EP3371327B1/en active Active
- 2016-11-01 US US15/773,154 patent/US20180321247A1/en not_active Abandoned
- 2016-11-01 CN CN202210906018.2A patent/CN115341033A/zh active Pending
- 2016-11-01 WO PCT/US2016/059877 patent/WO2017079139A1/en not_active Ceased
- 2016-11-01 CN CN201680078293.2A patent/CN108603233A/zh active Pending
- 2016-11-01 AU AU2016348401A patent/AU2016348401A1/en not_active Abandoned
- 2016-11-01 JP JP2018543010A patent/JP7043412B2/ja active Active
- 2016-11-01 CA CA3004150A patent/CA3004150A1/en active Pending
- 2016-11-01 EA EA201891085A patent/EA201891085A1/ru unknown
-
2018
- 2018-05-02 IL IL259093A patent/IL259093A/en unknown
-
2021
- 2021-01-06 US US17/142,767 patent/US20210405055A1/en not_active Abandoned
-
2023
- 2023-01-24 AU AU2023200364A patent/AU2023200364A1/en not_active Abandoned
-
2024
- 2024-07-11 US US18/770,366 patent/US20250180564A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250180564A1 (en) | 2025-06-05 |
| CA3004150A1 (en) | 2017-05-11 |
| CN115341033A (zh) | 2022-11-15 |
| AU2016348401A1 (en) | 2018-05-24 |
| EP3371327B1 (en) | 2024-12-18 |
| JP2018534595A (ja) | 2018-11-22 |
| AU2023200364A1 (en) | 2023-02-23 |
| EA201891085A1 (ru) | 2018-11-30 |
| JP7043412B2 (ja) | 2022-03-29 |
| EP3371327A1 (en) | 2018-09-12 |
| EP3371327A4 (en) | 2019-07-03 |
| US20210405055A1 (en) | 2021-12-30 |
| WO2017079139A1 (en) | 2017-05-11 |
| CN108603233A (zh) | 2018-09-28 |
| US20180321247A1 (en) | 2018-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259093A (en) | Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity | |
| IL292504B1 (en) | -methods of preparing t cells for t cell therapy | |
| HUS2500012I1 (hu) | B-sejtes rosszindulatú daganatok és más rákos megbetegedések kezelésére alkalmas autológ T-sejtek elõállításának módszerei és azok készítményei | |
| IL271005A (en) | Improved methods of cell culture for adoptive cell therapy | |
| EP3307876A4 (en) | MODIFIED NK-92 CELLS FOR THE TREATMENT OF CANCER | |
| EP2968549A4 (en) | CELL CULTURE METHOD | |
| DK3461491T3 (da) | Forbedret adoptiv celleterapi | |
| DK3523416T3 (da) | Fremgangsmåder og sammensætninger relateret til nk-celle- og anti-pdl1-kræftbehandlinger | |
| IL246262A0 (en) | Media for cell culture | |
| EP2968502A4 (en) | METHOD FOR CONTROLLING T-CELL PROLIFERATION | |
| DK3224351T3 (da) | Dyrkningsmedium til ekspandering af brystepitelstamceller | |
| PT2953634T (pt) | Métodos de expansão ou depleção das células t reguladoras | |
| PL3926051T3 (pl) | Sposoby zbierania hodowli komórek ssaczych | |
| GB2525104B (en) | Massively Parallel Single Cell Nucleic Acid Analysis | |
| EP3390695A4 (en) | ELECTROCHEMICAL HIGH PRESSURE CELL | |
| IL235739A0 (en) | Improved methods of cell culture for adoptive cell therapy | |
| HUE040233T2 (hu) | Szérummentes sejtkultúra-tápközeg | |
| IL254639A0 (en) | Digital analysis of cancer cells moving in the bloodstream in blood samples | |
| DK2900806T3 (da) | Tredimensionel celledyrkning | |
| IL270974A (en) | Methods of determining therapies based on single cell characterization of circulating tumor cells (ctcs) in metastatic disease | |
| EP2986710A4 (en) | AGE-MODIFIED CELLS AND METHOD FOR PRODUCING AGED-MODIFIED CELLS | |
| IL290429A (en) | Improved methods of genetically modifying animal cells | |
| IL250830B (en) | Early lung cancer detection by dna methylation phenotyping of sputum-derived cells | |
| DK3365107T3 (da) | Cellekultur | |
| EP4012024C0 (en) | METHOD FOR IMPROVING CELL THERAPY |